Pharm'Up

An E-platform for Learners

UK Pioneers CAR T Cell Therapy for Multiple Sclerosis: Single-Dose ‘Immune Reset’ Targets Autoimmune Disease

UK Pioneers CAR T Cell Therapy for Multiple Sclerosis: Single-Dose ‘Immune Reset’ Targets Autoimmune Disease

Pharm'Up

A patient in the UK has become the first person to receive CAR T cell therapy (obecabtagene...

FDA Moves to Ban Unapproved Fluoride Pills and Drops for Children, Citing Microbiome Risk and Outdated Science

FDA Moves to Ban Unapproved Fluoride Pills and Drops for Children, Citing Microbiome Risk and Outdated Science

Pharm'Up

The U.S. Food and Drug Administration (FDA) has announced a major policy shift, taking action to restrict...

Semaglutide (Ozempic/Wegovy) Cuts Major Heart Risks Independent of Weight Loss, SELECT Trial Analysis Confirms

Semaglutide (Ozempic/Wegovy) Cuts Major Heart Risks Independent of Weight Loss, SELECT Trial Analysis Confirms

Pharm'Up

A recent research study conducted by University College London (UCL) has unveiled a groundbreaking finding from the...

Pfizer Sues Metsera and Novo Nordisk in Delaware, Alleging Breach of Merger Deal and Anticompetitive Conspiracy

Pfizer Sues Metsera and Novo Nordisk in Delaware, Alleging Breach of Merger Deal and Anticompetitive Conspiracy

Pharm'Up

Pfizer Inc. has escalated its battle with competitor Novo Nordisk A/S by filing a major lawsuit against...

Groundbreaking Approval Kygevvi Receives FDA Nod as First Treatment for TK2 Deficiency (TK2d)

Groundbreaking Approval Kygevvi Receives FDA Nod as First Treatment for TK2 Deficiency (TK2d)

Pharm'Up

The U.S. Food and Drug Administration (FDA) has announced a landmark decision, approving Kygevvi (doxecitine and doxribtimine)...

USFDA Grants Tentative Approval to Zydus Lifesciences for Generic Crohn’s Disease Drug (Budesonide 4mg)

USFDA Grants Tentative Approval to Zydus Lifesciences for Generic Crohn’s Disease Drug (Budesonide 4mg)

Pharm'Up

Zydus Lifesciences Limited (Zydus) has achieved a significant regulatory milestone, securing tentative approval from the United States...

FDA Greenlights Lurbinectedin Combination for Extensive-Stage Small Cell Lung Cancer Maintenance, Extending Survival

FDA Greenlights Lurbinectedin Combination for Extensive-Stage Small Cell Lung Cancer Maintenance, Extending Survival

Pharm'Up

The U.S. Food and Drug Administration (FDA) has announced the approval of lurbinectedin (Zepzelca; Jazz Pharmaceuticals) in...

Pioneering Opioid Stewardship in Cancer Care MD Anderson’s Model for Patient Safety and Compassionate Pain Management

Pioneering Opioid Stewardship in Cancer Care MD Anderson’s Model for Patient Safety and Compassionate Pain Management

Pharm'Up

At The University of Texas MD Anderson Cancer Center, a dedicated opioid stewardship program is setting a...

Pharmacists as Anti-Stigma Champions: Key Strategies to Expand Buprenorphine Access for OUD

Pharmacists as Anti-Stigma Champions: Key Strategies to Expand Buprenorphine Access for OUD

Pharm'Up

The battle against the opioid epidemic requires more than just new medications; it demands a transformation in...

Pharmacist-Led Opioid Stewardship Program Critical for Safety in Cancer Care, Despite Regulatory Exemptions

Pharmacist-Led Opioid Stewardship Program Critical for Safety in Cancer Care, Despite Regulatory Exemptions

Pharm'Up

In a setting often overlooked by standard regulations, the University of Texas MD Anderson Cancer Center has...